OxyPrem awarded by Swiss Innovation Agency

20-01-2023 – OxyPrem among the Medtech start-ups enroute to transform the industry

After more than three years of milestone-based support and coaching, the Swiss Innovation Agency awarded five medtech start-ups the Innosuisse Certificate, in recognition for their readiness for external investment and sustainable growth. OxyPrem AG, spin-off of our Wyss Zurich project OxyPrem, is among those.

Similar News

22-02-2023

Recolony takes home CHF 150’000 winning the third stage of the Venture Kick competition

Recolony wins the third stage of the Venture Kick competition. The startup will use the funds to advance its cancer immunotherapy, aiming to regenerate the intestinal microbiota of cancer patients...

15-03-2023

MUVON co-founder and CEO interviewed by "Die Welt" (online version Gesunder Körper)

Dr. Deana Mohr explained, in this interview, her and her team's commitment to the stress incontinence topic and what they plan to achieve in the short and long term at MUVON.

16-03-2023

Nanoflex among the 10 super promising Swiss startups to watch in 2023 and beyond!

Nanoflex Robotics has been identified as one of the tenth early-stage Swiss startups that will shape the landscape in 2023 and skyrocket future ahead.